Carolina Mercado Acosta, MD
Ophthalmology · Miami, FLNPI 1326756123
Payments from drug & device makers
Across 50 payments — averaging $1151.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$56K
- Alcon$518
- Nova Eye, Inc.$344
- Rxsight Inc$163
- Sun Pharmaceutical Industries Inc.$146
- Johnson & Johnson Surgical Vision, Inc.$113
- plus $153 from 2 others
What the payments were for
- Consulting fees$9,77517%
- Grants$42,50074%
- Travel & lodging$2,5364%
- Food & beverage$2,7805%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 38 | $56,153 |
| Alcon | 3 | $518 |
| Nova Eye, Inc. | 1 | $344 |
| Rxsight Inc | 1 | $163 |
| Sun Pharmaceutical Industries Inc. | 1 | $146 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $113 |
| Mallinckrodt Hospital Products Inc. | 4 | $91 |
| Harrow Eye, LLC | 1 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS ELITE$12,565
- enVista MX60 IOL$12,565
- Trulign IOL$12,565
- Crystalens Accommodating IOL (AT-52AO)$12,565
- STELLARIS$228
- RXSIGHT CONTACT LENS$163
- RXSIGHT INJECTOR CARTRIDGE$163
- RXSIGHT INJECTOR HANDPIECE$163
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$163
- LIGHT ADJUSTABLE LENS (LAL)$163
- CEQUA$146
- TRYPTYR$125
- Tecnis Simplicity$113
- ENVISTA ENVY IOL$109
How this compares
$57,591 in reported general payments places this provider in the 85th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 59 | $2,378 |
| Loteprednol Etabonate | 13 | $1,749 |
| Ketorolac Tromethamine | 18 | $584 |
| ValacyclovirValacyclovir Hcl | 11 | $465 |
| MoxifloxacinMoxifloxacin Hcl | 24 | $444 |
| Latanoprost | 14 | $129 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 12 | $95 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Miami
- Guillermo AmescuaMiami$962K
- Felipe MedeirosMiami$935K
- Jennifer LohMiami$606K
- Jaclyn KovachMiami$590K
- William TrattlerMiami$580K
- Wilfredo LaraMiami$526K
- Jayanth SridharMiami$525K
- Kendall DonaldsonMiami$351K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.